Eagle Pharmaceuticals Inc expected to post earnings of $3.88 a share - Earnings Preview

Eagle Pharmaceuticals

06/05/2022 19:37

* Eagle Pharmaceuticals Inc  EGRX.OQ   EGRX.O  is expected
to show
a rise in quarterly revenue when it reports  results on May 9. 
    * The Woodcliff Lake New Jersey-based  company is expected
to
report  a 199.0% increase in revenue to $123.326 million from
$41.25 million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Eagle
Pharmaceuticals Inc
is for earnings of $3.88 per share. For the same quarter last
year, the company reported earnings of 24 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Eagle
Pharmaceuticals Inc is $49.5​, above​ its last closing price
of $43.68. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  0.96        0.94       0.85      Missed  -9.6
 Sep. 30 2021  0.83        0.83       0.56      Missed  -32.8
 Jun. 30 2021  0.75        0.80       0.93      Beat    16.3​
 Mar. 31 2021  0.74        0.65       0.24      Missed  -63.1
 ​​Dec.        -0.20       -0.17      0.96      Beat    656.5
 31 2020                                                
 Sep. 30 2020  0.33        0.30       1.17      Beat    296.6​
 Jun. 30 2020  0.26        0.24       0.57      Beat    142.6
 Mar. 31 2020  0.58        0.57       0.84      Beat    48
 This summary was machine generated May 6 at 18:37 GMT.  All
figures in US dollars  unless otherwise stated